After years of shrinking the prominence of commercial real estate in its portfolio, M&T Bank has hit its target and begun to ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization.

Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq: BNRG), a leading global energy provider ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Canadian oil exports outside of the U.S. have increased to about 6.5 per cent, up from 2.5 per cent, since May, while the ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its preliminary* fourth ...

Marla has worked in the healthcare industry since 2000, starting as a bench chemist with Pfizer in manufacturing. In 2006, ...

On November 22, 2024, the U.S. Food and Drug Administration approved Attruby, a near-complete TTR stabilizer, to reduce cardiovascular death and cardiovascular-related hospitalization in adult ...